A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis; OASIS-1

Press/Media: Press / Media

Period	2018 Oct 2

Title	A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis; OASIS-1
Media name/outlet	Clinical Trials.gov
Country	United States
Date	18/10/2
Persons	Hyun Jae Kim, Hyun Mee Kim, Jong Hyeok Park, Sung Rak Choi, Jongchul Park